Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Confidentiality CONTENTS Introduction ........................................... 14.2 Purpose.............................................................. 14.2 Policy ................................................................. 14.2 Health Insurance Portability and Accountability Act (HIPAA) ................. 14.3 Centers for Disease Control and Prevention guidance on HIPAA ............................................ 14.3 Alaska HIPAA policies ....................................... 14.3 National Guidelines .............................. 14.4 Resources and References ................. 14.5 A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Confidentiality 1 4 . 1 R e v i s e d N o v e m b e r 2 0 1 2
Introduction Purpose Use this section to determine what information and which records should be treated with confidentiality; identify state policy for maintaining patient confidentiality; take measures to ensure TB patients’ confidentiality; and determine when it is permissible to share information for public health reasons. The protection of private patient information is commonly referred to as confidentiality. Confidentiality involves the protection of information revealed during patient–healthcare worker encounters, including all written or electronic records of these encounters. Confidentiality is an essential issue in many different aspects of tuberculosis (TB) control. Healthcare workers need to be aware of confidentiality issues that are relevant to patient–healthcare worker encounters, as well as to the collection, management, and sharing of information gathered on TB patients. 1 Policy The State of Alaska has adopted a Health Insurance Portability and Accountability Act (HIPAA) policy that conforms to the national act. Information regarding Alaska DHSS HIPAA may be found at http://www.hss.state.ak.us/dhcs/HIPAA/default.htm Healthcare workers should keep patient information in confidence and divulge it only with the permission of the patient, except as otherwise required by law. 2 For roles and responsibilities, refer to the “Roles, Responsibilities, and Contact Information” topic in the Introduction 1.18. State Laws and Regulations Alaska regulations pertaining to patient confidentiality may be found in the Statutes and Regulations section of the manual 19.1. A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L C o n f i d e n t i a l i t y 1 4 . 2 R e v i s e d 1 1 / 2 0 1 2
- Page 293 and 294: Index Patient with Positive Acid-Fa
- Page 295 and 296: Index Patient with Negative Acid-Fa
- Page 297 and 298: Contact Evaluation, Treatment, and
- Page 299 and 300: Definition of abbreviations: HIV =
- Page 301 and 302: Note: An IGRA may be used in place
- Page 303 and 304: When to Expand a Contact Investigat
- Page 305 and 306: Figure 7: EVALUATION, TREATMENT, AN
- Page 307 and 308: CDC’s “Framework of Program Eva
- Page 309 and 310: Definitions of abbreviations: AIDS
- Page 311 and 312: elease assay; LTBI = latent tubercu
- Page 313 and 314: officials to distinguish between di
- Page 315 and 316: References 1 ATS, CDC, IDSA. Contro
- Page 317 and 318: 44 CDC, NTCA. Guidelines for the in
- Page 319 and 320: Introduction Purpose Use this secti
- Page 321 and 322: Available Laboratory Tests Table 2:
- Page 323 and 324: Table 3: PCR Testing Algorithm and
- Page 325 and 326: Table 4: SPECIMEN COLLECTION METHOD
- Page 327 and 328: 5. If possible, send the specimen o
- Page 329 and 330: Specimen Shipment There are three m
- Page 331 and 332: Resources and References Resources
- Page 333 and 334: Patient Education CONTENTS Introduc
- Page 335 and 336: treatment, common side-effects of m
- Page 337 and 338: Education Topics During the initial
- Page 339 and 340: 10. Explain the signs and symptoms
- Page 341 and 342: Patient Education Materials Get th
- Page 343: References 1 CDC. Module 4: treatme
- Page 347 and 348: National Guidelines The following g
- Page 349 and 350: Transfer Notifications CONTENTS Int
- Page 351 and 352: For roles and responsibilities, ref
- Page 353 and 354: Follow-Up Type When to Initiate Not
- Page 355 and 356: Action Transfers Within Alaska Tran
- Page 357 and 358: Provide the patient with a. A copy
- Page 359 and 360: References 1 CDC. International not
- Page 361 and 362: Infection Control CONTENTS Introduc
- Page 363 and 364: of TB infection control principles
- Page 365 and 366: Administrative Activities 13 Key ac
- Page 367 and 368: Personal Respiratory Protection Alt
- Page 369 and 370: For regulations in your area, refer
- Page 371 and 372: Employee Health All employees, phys
- Page 373 and 374: Figure 1: TWO STEP TESTING AND FOLL
- Page 375 and 376: Isolation To reduce disease transmi
- Page 377 and 378: Table 4: CRITERIA FOR PATIENTS TO B
- Page 379 and 380: When to Initiate Airborne Infection
- Page 381 and 382: Confirmed Tuberculosis Disease A pa
- Page 383 and 384: Multidrug-Resistant Tuberculosis Di
- Page 385 and 386: Environmental Controls in the Patie
- Page 387 and 388: Return to Work, School, or Other So
- Page 389 and 390: Tuberculosis Infection Control in P
- Page 391 and 392: Transportation Vehicles To prevent
- Page 393 and 394: 7 CDC. Guidelines for preventing th
Introduction<br />
Purpose<br />
Use this section to<br />
determine what information and which records should be treated with confidentiality;<br />
identify state policy for maintaining patient confidentiality;<br />
take measures to ensure TB patients’ confidentiality; and<br />
determine when it is permissible to share information for public health reasons.<br />
The protection <strong>of</strong> private patient information is commonly referred to as confidentiality.<br />
Confidentiality involves the protection <strong>of</strong> information revealed during patient–healthcare<br />
worker encounters, including all written or electronic records <strong>of</strong> these encounters.<br />
Confidentiality is an essential issue in many different aspects <strong>of</strong> tuberculosis (TB)<br />
control. Healthcare workers need to be aware <strong>of</strong> confidentiality issues that are relevant<br />
to patient–healthcare worker encounters, as well as to the collection, management, and<br />
sharing <strong>of</strong> information gathered on TB patients. 1<br />
Policy<br />
The <strong>State</strong> <strong>of</strong> <strong>Alaska</strong> has adopted a Health Insurance Portability and Accountability Act<br />
(HIPAA) policy that conforms to the national act. Information regarding <strong>Alaska</strong> DHSS<br />
HIPAA may be found at http://www.hss.state.ak.us/dhcs/HIPAA/default.htm<br />
Healthcare workers should keep patient information in confidence and divulge it only<br />
with the permission <strong>of</strong> the patient, except as otherwise required by law. 2<br />
For roles and responsibilities, refer to the “Roles, Responsibilities, and<br />
Contact Information” topic in the Introduction 1.18.<br />
<strong>State</strong> Laws and Regulations<br />
<strong>Alaska</strong> regulations pertaining to patient confidentiality may be found in the Statutes and<br />
Regulations section <strong>of</strong> the manual 19.1.<br />
A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L C o n f i d e n t i a l i t y 1 4 . 2<br />
R e v i s e d 1 1 / 2 0 1 2